Safety profile of HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 analysis

INTRODUCTION: BMS-663068 is a prodrug of BMS-626529, an attachment inhibitor that binds directly to HIV-1 gp120, preventing initial viral attachment and entry into the host CD4+ T-cell. AI438011 is an ongoing, Phase IIb, randomized, active-controlled trial investigating the safety, efficacy and dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalezari, Jacob, Latiff, Gulam H, Brinson, Cynthia, Echevarria, Juan, Treviño-Pérez, Sandra, Bogner, Johannes R, Stock, David, Joshi, Samit R, Hanna, George J, Lataillade, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Oral Presentation – Abstract O432B
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224850/
https://www.ncbi.nlm.nih.gov/pubmed/25394039
http://dx.doi.org/10.7448/IAS.17.4.19530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224850/
https://www.ncbi.nlm.nih.gov/pubmed/25394039
http://dx.doi.org/10.7448/IAS.17.4.19530

Ejemplares similares